EBookClubs

Read Books & Download eBooks Full Online

EBookClubs

Read Books & Download eBooks Full Online

Book Programs to Control Prescription Drug Costs Under Medicaid and Medicare Could be Strengthened

Download or read book Programs to Control Prescription Drug Costs Under Medicaid and Medicare Could be Strengthened written by United States. General Accounting Office and published by . This book was released on 1980 with total page 68 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Health Care

    Book Details:
  • Author : U S Government Accountability Office (G
  • Publisher : BiblioGov
  • Release : 2013-06
  • ISBN : 9781289096731
  • Pages : 72 pages

Download or read book Health Care written by U S Government Accountability Office (G and published by BiblioGov. This book was released on 2013-06 with total page 72 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Department of Health and Human Services (HHS) established two programs to contain the costs of prescription drugs under Medicaid and Medicare by setting upper limits on the amounts that could be reimbursed. One program, the Maximum Allowable Cost (MAC) Program, pertains to multiple-source drugs and is applicable to Medicaid and Medicare. The other program, the Estimated Acquisition Cost (EAC) Program, pertains to all drugs and is applicable only to Medicaid. GAO looked into the effectiveness of these programs in five States and obtained information on the effectiveness of State drug substitution laws nationwide.

Book Programs to control prescription drug costs under Medicaid and Medicare could be strengthened

Download or read book Programs to control prescription drug costs under Medicaid and Medicare could be strengthened written by United States. General Accounting Office and published by . This book was released on 1980 with total page 2 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Making Medicines Affordable

    Book Details:
  • Author : National Academies of Sciences, Engineering, and Medicine
  • Publisher : National Academies Press
  • Release : 2018-03-01
  • ISBN : 0309468086
  • Pages : 235 pages

Download or read book Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2018-03-01 with total page 235 pages. Available in PDF, EPUB and Kindle. Book excerpt: Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Book The Medicare Handbook

Download or read book The Medicare Handbook written by and published by . This book was released on 1992 with total page 12 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Medicare

    Book Details:
  • Author : Leslie G. Aronovitz (au)
  • Publisher : DIANE Publishing
  • Release : 2006-08
  • ISBN : 9781422306734
  • Pages : 88 pages

Download or read book Medicare written by Leslie G. Aronovitz (au) and published by DIANE Publishing. This book was released on 2006-08 with total page 88 pages. Available in PDF, EPUB and Kindle. Book excerpt: On Jan. 1, 2006, Medicare began providing coverage for outpatient prescription drugs through its new Part D benefit. Beneficiaries who enroll in Part D may choose a drug plan from those offered by private plan sponsors under contract to the Centers for Medicare & Medicaid Serv. (CMS), which administers the Part D benefit. Beneficiaries have until May 15, 2006, to enroll in the Part D benefit & select a plan without the risk of penalties. This report reviews the quality of CMS's commun. on the Part D benefit. This report: examined 70 CMS publications to select 6 documents to review & evaluate the clarity of these texts; made 500 calls to the 1-800-MEDICARE help line; & evaluated the usability of the Medicare Web site. Illus.

Book Prescription Drugs

    Book Details:
  • Author : Laura A. Dummit
  • Publisher : DIANE Publishing
  • Release : 2008-06
  • ISBN : 1437901352
  • Pages : 26 pages

Download or read book Prescription Drugs written by Laura A. Dummit and published by DIANE Publishing. This book was released on 2008-06 with total page 26 pages. Available in PDF, EPUB and Kindle. Book excerpt: In 2000, as the Congress considered adding a prescription drug (PD) benefit to Medicare, there was increased interest in understanding the ways that gov¿t. purchasers have controlled their costs for PD and whether these methods can be used to reduce PD costs for Medicare beneficiaries. One proposal would allow Medicare beneficiaries to purchase PD from pharmacies at the same prices that are available to fed. purchasers or state Medicaid programs. This report provides information on: the fed. drug price discounts available to fed. and non-fed. purchasers and the size of those discounts; and the potential effects that extending such discounts to non-fed. purchasers may have on outpatient drug prices paid by fed. and non-fed. purchasers. Illus.

Book Competition and the Cost of Medicare s Prescription Drug Program

Download or read book Competition and the Cost of Medicare s Prescription Drug Program written by Anna Cook and published by . This book was released on 2014-09-03 with total page 48 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (the Medicare Modernization Act, or MMA) substantially expanded the federal Medicare program by creating the prescription drug benefit known as Part D. In FY 2013, Medicare Part D covered 39 million people. The federal government spent $59 billion net of premiums on Part D in that year; after accounting for certain payments from states under the program, the net federal cost was $50 billion, which represented 10% of net federal spending for Medicare. A combination of broader trends in the prescription drug market and lower-than-expected enrollment in Part D has contributed to much lower spending for the program than projected when the MMA became law in 2003. This report examines the federal budgetary cost and competitive design of Medicare Part D and compares Medicare Part D and Medicaid Fee for Service. Figures and tables. This is a print on demand report.

Book The Role of NIH in Drug Development Innovation and Its Impact on Patient Access

Download or read book The Role of NIH in Drug Development Innovation and Its Impact on Patient Access written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2020-01-27 with total page 103 pages. Available in PDF, EPUB and Kindle. Book excerpt: To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.

Book Prescription Drugs  Overview of Approaches to Control Prescription Drug Spending in Federal Programs

Download or read book Prescription Drugs Overview of Approaches to Control Prescription Drug Spending in Federal Programs written by John E. Dicken and published by DIANE Publishing. This book was released on 2010-05 with total page 16 pages. Available in PDF, EPUB and Kindle. Book excerpt: Millions of individuals receive prescription drugs through fed. programs. The increasing cost of prescription drugs has put pressure to control drug spending on fed. programs such as the Fed. Employees Health Benefits Program (FEHBP), Medicare Part D, the VA, the DoD, and Medicaid. Prescription drug spending within the FEHBP in particular, which provides health and drug coverage to about 8 million fed. employees, retirees, and their dependents, has been a significant contributor to FEHBP cost and premium growth. This report describes approaches used by the FEHBP to control prescription drug spending and summarizes approaches used by other fed. programs. Illustrations.

Book Prescription Drugs  Oversight of Drug Pricing in Federal Programs

Download or read book Prescription Drugs Oversight of Drug Pricing in Federal Programs written by and published by DIANE Publishing. This book was released on 2007 with total page 18 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Prescription for Good Health

Download or read book Prescription for Good Health written by and published by . This book was released on 1992 with total page 84 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Issues in Designing a Prescription Drug Benefit for Medicare

Download or read book Issues in Designing a Prescription Drug Benefit for Medicare written by and published by . This book was released on 2002 with total page 76 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Medicaid Prescription Drugs

Download or read book Medicaid Prescription Drugs written by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and published by . This book was released on 2005 with total page 128 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Prescription Drug Pricing and Negotiation

Download or read book Prescription Drug Pricing and Negotiation written by United States. Congress. Senate. Committee on Finance and published by . This book was released on 2007 with total page 204 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Rare Diseases and Orphan Products

Download or read book Rare Diseases and Orphan Products written by Institute of Medicine and published by National Academies Press. This book was released on 2011-04-03 with total page 442 pages. Available in PDF, EPUB and Kindle. Book excerpt: Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.